Cases of Pulmonary embolism were observed in approximately 1.3% of patients with GIST and in approximately 0.8% of patients with MRCC, who received Sutent in Phase 3 studies (see section 4.4 - Venous Thromboembolic Events).
Kopsuarteri trombembooliat täheldati ligikaudu 1, 3% - l GIST- iga patsientidest ja umbes 0, 8% - l MRCC- ga patsientidest, kes said III faasi uuringutes SUTENTi (vt lõik 4. 4 – Venoosne trombemboolia).